Medicamen Organics Ltd. logo

Medicamen Organics was incorporated on March 15, 1995. The company is engaged in the development, manufacturing, and distribution of a broad range of pharmaceutical dosage forms, including generic tablets, capsules, oral liquids, ointments, gels, syrups, suspensions, and dry powders. It serves government (including both state and central governments) and private institutions as a contract manufacturer / third-party manufacturer.

Bidding Dates
21 Jun 2024 - 25 Jun 2024
Subscription
916.79x Oversubscribed
Minimum InvestmentMinimum LotMaximum LotLot SizeNumber of SharesIssue Price BandPost Issue Promoter Holding %Issue SizeIPO Document
₹128,0001140003.1 M₹32 - ₹3459.69 %₹99.2 M - ₹105.4 MRHP DOC

Medicamen Organics IPO SUBSCRIPTION STATUS

25 Jun '24
Total916.79x
Retail Individual Investor1729.76x
HNI (NII) Investors1772.95x
Qualified Institutional Buyers90.87x

Medicamen Organics IPO overall subscription rate was 916.79 times the total available shares

Medicamen Organics IPO retail subscription rate was 1729.76 times in the retail segment

Medicamen Organics IPO non-institutional investor subscription rate was 1772.95 times in the non-institutional investor category

Medicamen Organics IPO Qualified Institutional Bidder subscription rate was 90.87 times the available shares for Qualified Institutional Bidder

DayRetail Individual InvestorHNI (NII) InvestorsQualified Institutional Buyers
Category Reservation35%15%50%
25 Jun 2024
(Day 3)
1729.76x1772.95x90.87x
24 Jun 2024
(Day 2)
448.61x164.94x0.74x
21 Jun 2024
(Day 1)
95.42x43.93x0.53x

Medicamen Organics FINANCIALS

Period Net Profit (Rs in millions) Revenue from Operations (Rs in millions) Cash Flow from Operations (Rs in millions) Free Cash Flow (Rs in millions) Margins
FY24 24.0 252.7 -36.9 -40.3 18.8%
FY23 9.6 221.5 -5.8 -8.7 12.1%
FY22 1.0 209.8 0.4 -5.8 6.7%

Medicamen Organics IPO SUBSCRIPTION STATUS DETAILS

Medicamen Organics had 3.1 M shares on offer

Medicamen Organics IPO offer price was in the range ₹32 - ₹34

Medicamen Organics IPO minimum Investment was ₹128000

Medicamen Organics IPO issue size was ₹ 99.2 M - ₹ 105.4 M

Medicamen Organics had a minimum lot size of 4000 Shares per application

Medicamen Organics NUMBER OF SHARES ON OFFER

Total3.1 M
Fresh Issue3.1 M
Offer for Sale0
Post Issue Promoter Holding %59.69 %

Medicamen Organics IPO IMPORTANT DATES

Issue Open Date21 Jun 2024
Issue close Date25 Jun 2024
Allotment Date26 Jun 2024
Refund Date26 Jun 2024
Demat Account Credit Date27 Jun 2024
Listing Date28 Jun 2024
Listing on Exchange(s)NSE
Medicamen Organics Allotment StatusExchange

Medicamen Organics IPO subscription opened on 21 Jun 2024, and closed on 25 Jun 2024

IPO allotment for Medicamen Organics was finalized on Wednesday, 26 Jun 2024

IPO listing for Medicamen Organics was on NSE on Friday, 28 Jun 2024

Medicamen Organics IPO LISTING GAINS

Issue Price (adjusted)34.0
Listing Open Price137.8
Listing Close Price144.7
Listing Gain%305.4%
Current Gain%-34.7%

Medicamen Organics Peer

StockStock PriceMarket Cap (Rs crore)PE TTMPEG TTMPS TTMROE%ROA%Annual Revenue (Rs crore)Annual Revenue Growth %Annual Net Profit (Rs crore)Annual Net Profit Growth %EPS TTMEPS TTM Growth %
Medicamen Organics Ltd.22.226-8.80.11.1-14-7.822.7-40.7-4-199.3-2.5-173.2
Sun Pharmaceutical Industries Ltd.1884.9452250.741.28.37.313.710.660433.810.811479.4545.74.9
Divi's Laboratories Ltd.11180.5296807.288.32.524.315.312.81106714256817.2126.735.3
Torrent Pharmaceuticals Ltd.4689.5178373.584-112.310.325.84.913886.220.32163.413.255.8-0.7
Laurus Labs Ltd.2294.612398092.5115.816.88.46861.322.2888.814824.895.9
Zydus Lifesciences Ltd.1200120748.128.9-1.9418.69.627657.917.6504011.441.6-15

Medicamen Organics INFORMATION ON IPO ISSUE

About Medicamen Organics

Medicamen Organics was incorporated on March 15, 1995. The company is engaged in the development, manufacturing, and distribution of a broad range of pharmaceutical dosage forms, including generic tablets, capsules, oral liquids, ointments, gels, syrups, suspensions, and dry powders. It serves government (including both state and central governments) and private institutions as a contract manufacturer / third-party manufacturer.

Object of the Issue

  1. Funding of expenses proposed to be incurred towards product registration in the international markets
  2. Plant updation and increase in production capacity
  3. Funding working capital requirements of the company
  4. General corporate purposes

Medicamen Organics - PROMOTERS

Name
Bal Kishan Gupta

Medicamen Organics Lead Manager of the Issue

GYR Capital Advisors Private Limited

info@gyrcapitaladvisors.com

Medicamen Organics Registrar to the issue

Kfin Technologies Private Limited

nvl.ipo@kfintech.com

Medicamen Organics Strengths

Wide range of products

The company's product portfolio consists of 84 products. It operates under different brand names across the globe. Its business is diversified in terms of geographies and therapeutic areas within the pharmaceutical industry

Strength

Scalable business model

The company's business model is customer-centric and order-driven, requiring optimal utilization of existing resources to ensure quality supply and achieve economies of scale

Strength

Quality assurance

The company has been approved by WHO GMP since September 21, 2011, for Manufacturing Facility 1 and July 11, 2018, for Manufacturing Facility 2. It has also obtained ISO 9001:2015 certification for the Quality Management System from ISC

Strength

Medicamen Organics Risks

Dependent on few customers

The company is dependent on a few customers for sales. Loss of any of these large customers may affect the revenues and profitability

Risk

Litigation and claims

The company, its directors, and its promoters are parties to certain litigation and claims. These legal proceedings are pending at various levels of adjudication before different forums and regulatory authorities. Any adverse decision may result in liabilities or penalties and could adversely affect the business

Risk

IPO FAQs

  • The promoter of the company is Bal Kishan Gupta.
  • The category allocation of qualified institutional buyers is 50.0%, the category allocation of non individual investors or high networth individuals is 15.0% and for retail investors it is 35.0%.
  • The price band of the IPO is Rs 32.0 - 34.0.
  • The IPO application opens on Jun 21, 2024 and closes on Jun 25, 2024.
  • The minimum lot size for the IPO is 4000. The maximum lot size for the IPO is 4000.
  • For all category investors, the minimum application amount for this IPO is Rs. 128,000.0, the maximum value for this IPO is Rs 136,000.0.
  • This IPO will be allotted on Jun 26, 2024.
  • The refund will be credited to your account on Jun 26, 2024.
  • The allotted shares will be credited to your demat on Jun 27, 2024.
  • Medicamen Organics Ltd.’s shares listed on the stock exchanges on Jun 28, 2024.